Your browser doesn't support javascript.
loading
Efficacy and safety of dolutegravir-rilpivirine for maintenance of virological suppression in adults with HIV-1: 100-week data from the randomised, open-label, phase 3 SWORD-1 and SWORD-2 studies.
Aboud, Michael; Orkin, Chloe; Podzamczer, Daniel; Bogner, Johannes R; Baker, David; Khuong-Josses, Marie-Aude; Parks, David; Angelis, Konstantinos; Kahl, Lesley P; Blair, Elizabeth A; Adkison, Kimberly; Underwood, Mark; Matthews, Jessica E; Wynne, Brian; Vandermeulen, Kati; Gartland, Martin; Smith, Kimberly.
Afiliação
  • Aboud M; ViiV Healthcare, Brentford, UK.
  • Orkin C; Queen Mary University of London, London, UK.
  • Podzamczer D; IDIBELL-Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain.
  • Bogner JR; Hospital of the University of Munich, Munich, Germany.
  • Baker D; East Sydney Doctors, Darlinghurst, Sydney, NSW, Australia.
  • Khuong-Josses MA; CHG-Hôpital Delafontaine, Saint Denis, France.
  • Parks D; Central West Clinical Research, St Louis, MO, USA.
  • Angelis K; GlaxoSmithKline, Uxbridge, UK.
  • Kahl LP; ViiV Healthcare, Brentford, UK. Electronic address: lesley.p.kahl@viivhealthcare.com.
  • Blair EA; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Adkison K; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Underwood M; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Matthews JE; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Wynne B; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Vandermeulen K; Janssen Pharmaceutica, Beerse, Belgium.
  • Gartland M; ViiV Healthcare, Research Triangle Park, NC, USA.
  • Smith K; ViiV Healthcare, Research Triangle Park, NC, USA.
Lancet HIV ; 6(9): e576-e587, 2019 09.
Article em En | MEDLINE | ID: mdl-31307948
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Transcriptase Reversa / Inibidores de Integrase de HIV / Rilpivirina / Compostos Heterocíclicos com 3 Anéis Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet HIV Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Inibidores da Transcriptase Reversa / Inibidores de Integrase de HIV / Rilpivirina / Compostos Heterocíclicos com 3 Anéis Tipo de estudo: Clinical_trials Limite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet HIV Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido